Application

STILLWATER

Neurocrine Biosciences, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90272627
Filing Date: 10/22/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90272627
MARK INFORMATION
*MARK STILLWATER
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT STILLWATER
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Neurocrine Biosciences, Inc.
*MAILING ADDRESS 12780 El Camino Real
*CITY San Diego
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92130
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 042 
*IDENTIFICATION Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; Pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing medical information; providing research information to patients and practitioners as to the results of clinical trials; providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders; providing research information to patients and practitioners as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Allison Strickland Ricketts
ATTORNEY DOCKET NUMBER NEUB 2010603
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME FROSS ZELNICK LEHRMAN & ZISSU, P.C.
STREET 151 West 42nd St., 17th Fl
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10036
PHONE 212-813-5967
EMAIL ADDRESS ricketts-docket@fzlz.com
OTHER APPOINTED ATTORNEY Lawrence E. Apolzon, Andrew N. Fredbeck, Nancy Sabarra, Karen Lim, Charles T.J. Weigell, Ashford Tucker, Tamar Niv Bessinger
CORRESPONDENCE INFORMATION
NAME Allison Strickland Ricketts
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ricketts-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 550
*TOTAL FEES PAID 550
SIGNATURE INFORMATION
SIGNATURE /David L. Bradfute/
SIGNATORY'S NAME David L. Bradfute, PhD, JD
SIGNATORY'S POSITION Vice President & Head, Intellectual Property
DATE SIGNED 10/22/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90272627
Filing Date: 10/22/2020

To the Commissioner for Trademarks:

MARK: STILLWATER (Standard Characters, see mark)
The literal element of the mark consists of STILLWATER. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Neurocrine Biosciences, Inc., a corporation of Delaware, having an address of
      12780 El Camino Real
      San Diego, California 92130
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 042:  Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; Pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Providing medical information; providing research information to patients and practitioners as to the results of clinical trials; providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders; providing research information to patients and practitioners as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Allison Strickland Ricketts. Other appointed attorneys are Lawrence E. Apolzon, Andrew N. Fredbeck, Nancy Sabarra, Karen Lim, Charles T.J. Weigell, Ashford Tucker, Tamar Niv Bessinger. Allison Strickland Ricketts of FROSS ZELNICK LEHRMAN & ZISSU, P.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      151 West 42nd St., 17th Fl
      New York, New York 10036
      United States
      212-813-5967(phone)
      ricketts-docket@fzlz.com
The docket/reference number is NEUB 2010603.
Allison Strickland Ricketts submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Allison Strickland Ricketts
       PRIMARY EMAIL FOR CORRESPONDENCE: ricketts-docket@fzlz.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /David L. Bradfute/   Date: 10/22/2020
Signatory's Name: David L. Bradfute, PhD, JD
Signatory's Position: Vice President & Head, Intellectual Property
Payment Sale Number: 90272627
Payment Accounting Date: 10/22/2020

Serial Number: 90272627
Internet Transmission Date: Thu Oct 22 19:31:08 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2020102219310844
1439-90272627-750cceaf4808717317ab72f494
dfa8e1d25eeeb2809571d514899e6f3ac337e59a
-DA-31081758-20201022171448427743

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed